Preventing acute kidney injury in high-risk patients

Clicks: 18
ID: 321167
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #17 of 145 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 145 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Acute kidney injury (AKI) is a complex and heterogeneous clinical syndrome associated with substantial short- and long-term morbidity and mortality. AKI outcomes are strongly influenced by severity, duration, and recovery trajectory, with persistent AKI conferring a worse prognosis and higher risk of progression to chronic kidney disease (CKD). Early AKI detection is limited by the impediments of traditional functional criteria based on serum creatinine and urine output. Stress and damage biomarkers have demonstrated promise for early identification of subclinical AKI and for assessing risk of progression before a functional decline becomes apparent. Preventive strategies remain the foundation of AKI management. The KDIGO AKI care bundle, comprising haemodynamic optimisation, close monitoring of kidney function parameters, and avoidance of nephrotoxins and hyperglycemia, has demonstrated the strongest evidence-based approach for preventing AKI, especially when stress is early identified by biomarkers. Evidence for adjunctive interventions, including remote ischaemic preconditioning and selected pharmacological agents, remains inconsistent and context-dependent. Current evidence supports a paradigm shift towards earlier risk identification, biomarker-guided stratification, and early proactive implementation of targeted preventive strategies.
Reference Key
openalex_W7168365911 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Melanie Meersch-Dini, Michael Joannidis
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag228
URL
https://doi.org/10.1093/ckj/sfag228
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.